James L. Reading
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 6
-
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 3
- Co-authors
- Charles Swanton (9 shared papers)Sergio A. Quezada (9 shared papers)Nicholas McGranahan (3 shared papers)Rachel Rosenthal (2 shared papers)Kevin Litchfield (5 shared papers)Andrew Rowan (3 shared papers)Samra Turajlic (2 shared papers)Hang Xu (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Nature Communications (2 papers)Cancer Cell (2 papers)Annals of Oncology (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
James L. Reading
29 papers receiving 1.4k citations
James L. Reading's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 619
- Immunology 472
- Cancer Research 225
- Genetics 80
- Pulmonary and Respiratory Medicine 226
Countries citing papers authored by James L. Reading
This map shows the geographic impact of James L. Reading's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Reading with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Reading more than expected).
Fields of papers citing papers by James L. Reading
This network shows the impact of papers produced by James L. Reading. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Reading. The network helps show where James L. Reading may publish in the future.
Co-authors
The 25 scholars most cited alongside James L. Reading, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis Hit paper breakdown → | 2017 | 676 |
| 2 | 2018 | 121 | |
| 3 | 2017 | 97 | |
| 4 | Clinical consequences of antiphospholipid antibodies: an historic cohort study. | 1994 | 81 |
| 5 | 2020 | 71 | |
| 6 | 2013 | 56 | |
| 7 | 1995 | 56 | |
| 8 | 2015 | 45 | |
| 9 | 1995 | 37 | |
| 10 | 2015 | 37 | |
| 11 | 2024 | 23 | |
| 12 | 2007 | 22 | |
| 13 | 2012 | 13 | |
| 14 | 2018 | 13 | |
| 15 | 2011 | 12 | |
| 16 | 2021 | 7 | |
| 17 | 2012 | 6 | |
| 18 | 2016 | 6 | |
| 19 | 2020 | 5 | |
| 20 | 2023 | 4 |
About James L. Reading
James L. Reading is a scholar working on Oncology, Immunology, Surgery, Molecular Biology and Cancer Research, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer Genomics and Diagnostics (3 papers), T-cell and B-cell Immunology (3 papers), Immune Cell Function and Interaction (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Oncology (619 citations), Immunology (472 citations), Cancer Research (225 citations), Genetics (80 citations) and Pulmonary and Respiratory Medicine (226 citations). James L. Reading has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Charles Swanton, Sergio A. Quezada, Nicholas McGranahan, Rachel Rosenthal, Kevin Litchfield, Andrew Rowan, Samra Turajlic, Hang Xu, James Larkin and Yien Ning Sophia Wong. Their work appears in journals such as Journal of Clinical Oncology, Nature Communications, Cancer Cell, Annals of Oncology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.